Back to Search
Start Over
Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al .
- Source :
-
Annals of the rheumatic diseases [Ann Rheum Dis] 2022 May; Vol. 81 (5), pp. e74. Date of Electronic Publication: 2020 May 20. - Publication Year :
- 2022
-
Abstract
- Competing Interests: Competing interests: TIK has received personal fees from Novartis. MM has received grants from Novartis and Biogen, and has received personal fees from Novartis, Biogen, Merck, Sanofi Genzyme and Teva. FTS has received grants and personal fees from Biogen, Merck, Novartis, Sanofi Genzyme and Roche. JA has received grants from AbbVie, BMS, Eli Lilly, MSD, Pfizer, Roche, Samsung Bioepis, Sanofi and UCB. LD has received grants from BMS and has received personal fees from Eli Lilly and Galderma.
Details
- Language :
- English
- ISSN :
- 1468-2060
- Volume :
- 81
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Annals of the rheumatic diseases
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32434821
- Full Text :
- https://doi.org/10.1136/annrheumdis-2020-217802